DTP-poliovirus vaccine - Kaketsuken

Drug Profile

DTP-poliovirus vaccine - Kaketsuken

Alternative Names: Diphtheria tetanus pertussis and inactivated poliovirus vaccine - Kaketsuken; Quattrovac

Latest Information Update: 01 Nov 2012

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Kaketsuken
  • Class Bacterial vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Diphtheria; Pertussis; Poliomyelitis; Tetanus

Most Recent Events

  • 31 Oct 2012 Launched for Diphtheria in Japan (SC) - First global launch
  • 31 Oct 2012 Launched for Pertussis in Japan (SC) - First global launch
  • 31 Oct 2012 Launched for Poliomyelitis in Japan (SC) - First global launch
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top